Contact your healthcare provider if you experience: Bruises larger than two inches in diameter or that continue expanding after 24 hours Severe pain at the injection site that interferes with daily activities or doesn't improve within 48 hours Signs of infection including increasing warmth, redness spreading beyond the immediate injection site, purulent drainage, or fever above 100.4F (38C) Bruising that persists beyond three weeks without improvement Development of a hard lump or nodule beneath the skin that doesn't resolve Sudden increase in bruising frequency or severity compared to your usual pattern Bruising accompanied by unusual bleeding from other sites (gums, nose, or in urine/stool) Patients taking anticoagulant medications require particular vigilance
In a systematic review article that included 40 clinical trials, tirzepatide at 15 mg ranked first in terms of HbA1c reduction rate, compared to other GLP-1RA-based strategies, and even those including insulin
What sets GHK-Cu apart from most cosmetic peptides is the depth of scientific evidence supporting its efficacy
This is from immediate barrier support, not collagen changes
Michael White, head of the department of pharmacy practice at the University of Connecticut, tells TODAY.com